WallStSmart
UNH

UnitedHealth Group Incorporated

NYSE: UNH · HEALTHCARE · HEALTHCARE PLANS

$413.00
+1.58% today

Updated 2026-06-09

Market cap
$343.21B
P/E ratio
28.50
P/S ratio
0.76x
EPS (TTM)
$13.26
Dividend yield
2.33%
52W range
$230 – $404
Volume
8.0M

WallStSmart proprietary scores

54
out of 100
Grade: C
Hold
Investment rating
5.3
Growth
C+
5.5
Quality
C+
5.5
Profitability
C+
4.7
Valuation
C
4/9
Piotroski F-Score
Moderate
2.3
Altman Z-Score
Grey zone
Industry rank
View all highly rated stocks (75+) →209 stocks currently score above 75

Price targets

Analyst target
$407.38
-1.36%
12-Month target
$216.44
-47.59%
Intrinsic (DCF)
$321.13
Margin of safety
-26.61%
6 Strong Buy16 Buy5 Hold1 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
+ Free cash flow $8.15B — positive
Risks
- Thin margins at 2.68%
- 26.61% above intrinsic value

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM2026 (E)
Revenue$324.16B$371.62B$400.28B$447.57B$449.71B$444.4B
Net income$20.12B$22.38B$14.40B$12.06B$6.28B
EPS$13.26$18.39
Free cash flow$23.40B$25.68B$20.70B$16.07B$8.15B
Profit margin6.21%6.02%3.60%2.69%2.68%

Recent insider activity

DateInsiderTypeSharesPrice
2026-06-03ZAETTA, CHRISTOPHER RSale134$377.00
2026-06-02CONWAY, PATRICK HUGHSale204$377.92
2026-04-23CONWAY, PATRICK HUGHSale800$355.00

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
UNH$343.21B545.35.54.75.5-26.61%Buy
LLY$948.95B7810.010.05.06.0Strong Buy
JNJ$536.54B594.79.03.36.0-71.41%Buy
ABBV$380.57B634.08.04.05.0-55.64%Buy
AZN$286.37B646.08.56.05.0+6.79%Buy
MRK$285.64B503.38.02.75.0-49.34%Hold

Smart narrative

UnitedHealth Group Incorporated trades at $413.00. representing a P/E of 28.50x trailing earnings. Our Smart Value Score of 54/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.28, it sits in the grey zone. TTM revenue stands at $449.71B. with profit margins at 2.68%. Our DCF model estimates intrinsic value at $321.13.

Frequently asked questions

What is UnitedHealth Group Incorporated's stock price?

UnitedHealth Group Incorporated (UNH) trades at $413.00, on a P/E of 28.5x and a P/S of 0.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is UnitedHealth Group Incorporated overvalued?

UnitedHealth Group Incorporated carries a Smart Value Score of 54/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $321.13 against the $413.00 price, so on cash flow terms the market is paying a premium for UnitedHealth Group Incorporated's growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.

What is the price target of UnitedHealth Group Incorporated (UNH)?

The 12-month analyst consensus target is $407.38, about 1.4% below the current $413.00. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

What is the future stock price of UNH by 2030?

Our research-backed model puts the 2030 base case at $626.50, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.

What is the intrinsic value of UnitedHealth Group Incorporated (UNH)?

Our DCF model estimates intrinsic value at $321.13, a -26.6% margin of safety versus today's $413.00. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.

What is UnitedHealth Group Incorporated's revenue?

UnitedHealth Group Incorporated's trailing twelve-month revenue is $449.71B, and our model projects it reaching about $579.10B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.

Altman Z-Score?

UnitedHealth Group Incorporated's Altman Z-Score is 2.28, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryHEALTHCARE PLANS
CountryUSA
ExchangeNYSE
CurrencyUSD

Quick metrics

P/S ratio0.76x
ROE11.59%
Beta0.65
50D MA$342.37
200D MA$327.68
Shares out0.91B
Float0.91B
Short ratio
Avg volume8.0M

Performance

1 week+5.96%
1 month+3.91%
3 months+40.04%
YTD+21.95%
1 year+35.23%
3 years-14.13%
5 years